|
Effect of Some Drugs on Rheumatoid Arithritis Activity
RECRUITINGPhase 3Sponsored by Sherief Abd-Elsalam
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2018-10-01
Est. completion2026-10
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03770923
Summary
Effect of Some Drugs on Rheumatoid Arithritis Activity.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Rheumatoid arthritis Exclusion Criteria: * liver or renal disease
Conditions2
ArthritisRheumatoid Arthritis
Interventions2
Related trials
- Efficacy of Montelukast on STEMl Patients — Shanghai Zhongshan Hospital
- Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes — University of Colorado, Denver
- Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma — Benjamin T Diamond, MD
- Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial — Emory University
- MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) — Austin V Stone
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2018-10-01
Est. completion2026-10
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03770923